Literature DB >> 25219574

Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.

Kazutoshi Yamada1, Eishiro Mizukoshi, Hajime Sunagozaka, Kuniaki Arai, Tatsuya Yamashita, Yumie Takeshita, Hirofumi Misu, Toshinari Takamura, Seiko Kitamura, Yoh Zen, Yasuni Nakanuma, Masao Honda, Shuichi Kaneko.   

Abstract

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is closely related to insulin resistance and lipid metabolism. Recent studies have suggested that the quality of fat accumulated in the liver is associated with the development of nonalcoholic steatohepatitis (NASH). In this study, we investigated the fatty acid composition in liver tissue and its association with the pathology in NAFLD patients.
METHODS: One hundred and three patients diagnosed with NAFLD [simple steatosis (SS): 63, NASH: 40] were examined and their hepatic fatty acids were measured using gas chromatography. In addition, relationships between the composition and composition ratios of various fatty acids and patient backgrounds, laboratory test values, histology of the liver, and expression of fat metabolism-related enzymes were investigated.
RESULTS: The C16:1n7 content, the C16:1n7/C16:0 and C18:1n9/C18:0 ratios were increased and the C18:0/C16:0 ratio was decreased in the NASH group. The C18:0/C16:0 and C18:1n9/C18:0 ratios were associated with the steatosis score in liver tissue, and the C16:1n7/C16:0 ratio was associated with the lobular inflammation score. The expressions levels of genes: SCD1, ELOVL6, SREBP1c, FAS and PPARγ were enhanced in the NASH group. In multivariate analysis, the C18:0/C16:0 ratio was the most important factor that was correlated with the steatosis score. In contrast, the C16:1n7/C16:0 ratio was correlated with lobular inflammation.
CONCLUSION: The fatty acid composition in liver tissue and expression of genes related to fatty acid metabolism were different between the SS and NASH groups, suggesting that the acceleration of fatty acid metabolism is deeply involved in pathogenesis of NASH.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  fatty acid metabolism; insulin resistance; palmitic acid; toxic lipid

Mesh:

Substances:

Year:  2014        PMID: 25219574     DOI: 10.1111/liv.12685

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  43 in total

1.  Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Xiaobo Wang; Ze Zheng; Jorge Matias Caviglia; Kathleen E Corey; Tina M Herfel; Bishuang Cai; Ricard Masia; Raymond T Chung; Jay H Lefkowitch; Robert F Schwabe; Ira Tabas
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

2.  Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.

Authors:  Takashi Nakahara; Hideyuki Hyogo; Atsushi Ono; Yuko Nagaoki; Tomokazu Kawaoka; Daiki Miki; Masataka Tsuge; Nobuhiko Hiraga; Clair Nelson Hayes; Akira Hiramatsu; Michio Imamura; Yoshiiku Kawakami; Hiroshi Aikata; Hidenori Ochi; Hiromi Abe-Chayama; Hisako Furusho; Tomoaki Shintani; Hidemi Kurihara; Mutsumi Miyauchi; Takashi Takata; Koji Arihiro; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2017-07-24       Impact factor: 7.527

3.  Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome.

Authors:  Andrew E Libby; Elise Bales; David J Orlicky; James L McManaman
Journal:  J Biol Chem       Date:  2016-09-27       Impact factor: 5.157

4.  Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis.

Authors:  Dirk J van der Windt; Vikas Sud; Hongji Zhang; Patrick R Varley; Julie Goswami; Hamza O Yazdani; Samer Tohme; Patricia Loughran; Robert M O'Doherty; Marta I Minervini; Hai Huang; Richard L Simmons; Allan Tsung
Journal:  Hepatology       Date:  2018-07-16       Impact factor: 17.425

5.  A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonation.

Authors:  Beyza Bulutoglu; Camilo Rey-Bedón; Young Bok Abraham Kang; Safak Mert; Martin L Yarmush; O Berk Usta
Journal:  Lab Chip       Date:  2019-09-10       Impact factor: 6.799

6.  High Choline Intake during Pregnancy Reduces Characteristics of the Metabolic Syndrome in Male Wistar Rat Offspring Fed a High Fat But Not a Normal Fat Post-Weaning Diet.

Authors:  Rola Hammoud; Emanuela Pannia; Ruslan Kubant; Adam Metherel; Rebecca Simonian; Zdenka Pausova; G Harvey Anderson
Journal:  Nutrients       Date:  2021-04-24       Impact factor: 5.717

7.  Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis.

Authors:  Petra Hirsova; Gregory J Gores
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-01

Review 8.  The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update.

Authors:  Aleksandra Hliwa; Bruno Ramos-Molina; Dariusz Laski; Adriana Mika; Tomasz Sledzinski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

9.  Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.

Authors:  Noriko Suzuki-Kemuriyama; Takashi Matsuzaka; Motoko Kuba; Hiroshi Ohno; Song-Iee Han; Yoshinori Takeuchi; Masaaki Isaka; Kazuto Kobayashi; Hitoshi Iwasaki; Shigeru Yatoh; Hiroaki Suzuki; Katsuhiro Miyajima; Dai Nakae; Naoya Yahagi; Yoshimi Nakagawa; Hirohito Sone; Nobuhiro Yamada; Hitoshi Shimano
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

10.  Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.

Authors:  Franck Chiappini; Christophe Desterke; Justine Bertrand-Michel; Catherine Guettier; François Le Naour
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.